col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


37 Ergebisse       Seite 1

 [1] 
Elsevier: International Journal of Pharmaceutics
  Original Artikel Datum Titel Autoren   Max. 6 Autoren
1 [GO] 2026―Jun―01 Intranasal administration of a DNA vaccine complexed with sugar-functionalized chitosan induces protective immunity against SARS-CoV-2 in mice Mariana Colaço, João Panão-Costa, Filipa Lebre, Ernesto Alfaro-Moreno, Olga Borges
2 [GO] 2025―Okt―10 Endosomal escape and current obstacles in ionizable lipid nanoparticles mediated gene delivery: lessons from COVID-19 vaccines Semmal Syed Meerasa, Aqeel Ahmad, Amer Ali Khan, Shafiul Haque, Imran Saleem
3 [GO] 2025―Aug―15 Targeting CCL2 silencing using polymer-lipid hybrid nanoparticles to reduce cytokine storm and inflammation in severe COVID-19 Heloísa Athaydes Seabra Ferreira, Lays Cordeiro Guimarães, Pedro Augusto Carvalho Costa, Caroline Leonel Vasconcelos de Campos, Sérgio Ricardo Aluotto Scalzo Júnior, Celso Martins Queiroz-Júnior, Maria Marta Figueiredo, Mauro Martins Teixeira, Vivian Vasconcelos Costa, Pedro Pires Goulart Guimaraes
4 [GO] 2025―Aug―05 An intranasal quadruple variant vaccine approach using SARS-CoV-2 and influenza A: Delta, Omicron, H1N1and H3N2 Revanth Singh, Mahek Gulani, Sharon Vijayanand, Tanisha Arte, Emmanuel Adediran, Dedeepya Pasupuleti, Parth Patel, Amarae Ferguson, Mohammad Uddin, Susu M. Zughaier, Martin J. D’souza
5 [GO] 2025―Jul―15 Comprehensive review on emerging nanotechnologies for combating COVID-19 and future pandemic preparedness ZuanLei Liang, Guangcun Shan, Shizhe Shan, Zejian Ding, Jiliang Zhang, Bingfeng Chu
6 [GO] 2025―Jun―08 Carboxymethyl-starch:iodine complexes as virucidal agents: salivary amylase triggers on-site iodine release, preventing human coronavirus OC43 replication Salma Tajer, Yong Xiao, Benoit Barbeau, Mircea Alexandru Mateescu
7 [GO] 2025―Mai―26 A spray dried replicon vaccine platform for pandemic response Wynton D. McClary, John Z. Chen, Hui Wang, Ethan Lo, Julie Bakken, Joseph McCollum, Christopher Press, Eduard Melief, Devin S. Brandt, Andrew R. Martin, Reinhard Vehring, Darshan N. Kasal, Emily A. Voigt, Alana Gerhardt
8 [GO] 2025―Apr―23 Pulmonary delivery of clofoctol-loaded nanoparticles inhibits SARS-CoV-2 replication and reduces pneumonia Tom Bourguignon, Jesus Alfredo Godinez-Leon, Amine Pochet, Tahmida Shamsuddin, Valentin Sencio, Jonathan Chatagnon, Axelle Grandé, Joan Fine, Séverine Heumel, Cyril Robil, Lou Delval, Catherine Piveteau, Sandrine Belouzard, Priscille Brodin, François Trottein, Arnaud Machelart, Ruxandra Gref
9 [GO] 2025―Mrz―18 Practical approach to development of GS-445124-loaded PLGA nanoparticles for the long-term treatment of feline infectious peritonitis caused by feline coronavirus infection Minki Jin, Hyun-Jin Cho, Young-Guk Na, Taek-Seon Yun, Bomin Song, Sang-Rae Lee, Seonho Je, Hong-Geun Oh, Yang-Gyu Park, Jinhyung Rho, Mi-Jin Yang, Jin Soo Shin, Jong-Suep Baek, Hong-Ki Lee, Tae-Won Kim, Cheong-Weon Cho
10 [GO] 2025―Jan―30 Inhalable spray-dried dry powders combining ivermectin and niclosamide to inhibit SARS-CoV-2 infection in vitro Catherine Su, Tushar Saha, Shubhra Sinha, Cody P. Hird, Sophie X.Y. Smith, Miguel E. Quiñones-Mateu, Shyamal C. Das
11 [GO] 2024―Jul―26 Inhalable dry powders of a monoclonal antibody against SARS-CoV-2 virus made by thin-film freeze-drying Haiyue Xu, Sawittree Sahakijpijarn, Chaeho Moon, Christopher J. Emig, Marco Mena, Steven J. Henry, Adela Vitug, Christian John Ventura, Philip J. Kuehl, David Revelli, Donald E. Owens, Dale J. Christensen, Robert O. Williams, Zhengrong Cui
12 [GO] 2024―Jun―26 Targetable domains for the design of peptide-dendrimer inhibitors of SARS-CoV-2 Rosa Bellavita, Speranza Esposito, Simone Braccia, Laura Madrid, Paula Ortega, Gabriella D’Auria, Federica Zarrilli, Felice Amato, Stefania Galdiero, Javier de la Mata, Lucia Falcigno, Annarita Falanga
13 [GO] 2024―Mai―24 Raman and NIR spectroscopy-based real-time monitoring of the membrane filtration process of a recombinant protein for the diagnosis of SARS-CoV2 Dorottya Vaskó, Eszter Pantea, Júlia Domján, Csaba Fehér, Orsolya Mózner, Balázs Sarkadi, Zsombor K. Nagy, György J. Marosi, Edit Hirsch
14 [GO] 2024―Mrz―16 Nasal delivery of encapsulated recombinant ACE2 as a prophylactic drug for SARS-CoV-2 Alberto Baldelli, Chun Yuen Jerry Wong, Hale Oguzlu, Hanieh Gholizadeh, Yigong Guo, Hui Xin Ong, Anika Singh, Daniela Traini, Anubhav Pratap-Singh
15 [GO] 2024―Feb―29 Mannosylated polyethylenimine-cholesterol-based nanoparticles for targeted delivery of minicircle DNA vaccine against COVID-19 to antigen-presenting cells Dalinda Eusébio, Milan Paul, Swati Biswas, Zhengrong Cui, Diana Costa, Ângela Sousa.
16 [GO] 2023―Aug―15 Assessing the physicochemical stability and intracellular trafficking of mRNA-based COVID-19 vaccines Benedetta Fongaro, Benedetta Campara, Giulia Yuri Moscatiello, Ada De Luigi, Davide Panzeri, Laura Sironi, Paolo Bigini, Giovanni Carretta, Giorgia Miolo, Gianfranco Pasut, Patrizia Polverino De Laureto
17 [GO] 2023―Jul―02 Bivalent mRNA vaccines against three SARS-CoV-2 variants mediated by new ionizable lipid nanoparticles Ji Wang, Yanhao Zhang, Shuo Dong, Wenhui Zha, Chao Liu, Yang Wang, Yuhao Jiang, Hanlei Xing, Xinsong Li
18 [GO] 2023―Mai―13 Aqueous cannabidiol β-cyclodextrin complexed polymeric micelle nasal spray to attenuate in vitro and ex-vivo SARS-CoV-2-induced cytokine storms Narumon Changsan, Somchai Sawatdee, Roongnapa S, Charisopon Chunhachaichana, Teerapol Srichana
19 [GO] 2023―Apr―05 Functionalized protein microparticles targeting hACE2 as a novel preventive strategy for SARS-CoV-2 infection Yujia Li, Yike Huang, Kehui Zhu, Xiaoqiong Duan, Shilin Li, Min Xu, Chunhui Yang, Jiaxin Liu, Hans Bäumler, Pin Yu, He Xie, Bin Li, Ye Cao, Limin Chen
20 [GO] 2023―Mrz―01 Cuprous oxide nanoparticles incorporated into a polymeric matrix embedded in fabrics to prevent spread of SARS-CoV-2 Nadina Usseglio, Renée Onnainty, Brenda Konigheim, Javier Aguilar, Juan Pablo Petiti, Giuliana Lingua, Carolina Leimgruber, Juan Cruz Bonafé Allende, Alicia Torres, Gladys Granero
21 [GO] 2022―Nov―19 Recent updates on liposomal formulations for detection, prevention and treatment of coronavirus disease (COVID-19) Nur Dini Fatini Mohammad Faizal, Mohd Cairul Iqbal Mohd Amin
22 [GO] 2022―Okt―02 An efficient approach for SARS-CoV-2 monoclonal antibody production via modified mRNA-LNP immunization Fu-Fei Hsu, Kang-Hao Liang, Monika Kumari, Wan-Yu Chen, Hsiu-Ting Lin, Chao-Min Cheng, Mi-Hua Tao, Han-Chung Wu
23 [GO] 2022―Jul―20 Inhaled Therapy for COVID-19: Considerations of Drugs, Formulations and Devices Tushar Saha, Miguel E. Quiñones-Mateu, Shyamal C. Das
24 [GO] 2022―Mrz―19 Pharmacokinetics and Safety of Inhaled Ivermectin in Mice as a Potential COVID-19 Treatment Ahmed H. Albariqi, Yuncheng Wang, Rachel Yoon Kyung Chang, Diana H. Quan, Xiaonan Wang, Stefanie Kalfas, John Drago, Warwick J. Britton, Hak-Kim Chan
25 [GO] 2021―Okt―22 Innovative vaccine platforms against infectious diseases: under the scope of the COVID-19 pandemic Maria Tsakiri, Nikolaos Naziris, Costas Demetzos
26 [GO] 2021―Sep―23 Targeted pulmonary drug delivery in coronavirus disease (COVID-19) therapy: A patient-specific in silico study based on magnetic nanoparticles-coated microcarriers adhesion Sina Ebrahimi, Amir Shamloo, Mojgan Alishiri, Yasaman Mozhdehbakhsh Mofrad, Fatemeh Akherati
27 [GO] 2021―Sep―21 Inhaled Edoxaban dry powder inhaler formulations: Development, characterization and their effects on the coagulopathy associated with COVID-19 infection Md Abdur Rashid, Saiqa Muneer, Jayanti Mendhi, Mohammad Zaidur Rahman Sabuj, Yahya Alhamhoom, Yin Xiao, Tony Wang, Emad L Izake, Nazrul Islam
28 [GO] 2021―Aug―18 Assessment of adjuvantation strategy of lipid squalene nanoparticles for enhancing the immunogenicity of a SARS-CoV-2 spike subunit protein against COVID-19 Hui-Min Ho, Chiung-Yi Huang, Yu-Jhen Cheng, Kuan-Yin Shen, Tsai-Teng Tzeng, Shih-Jen Liu, Hsin-Wei Chen, Chung-Hsiung Huang, Ming-Hsi Huang
29 [GO] 2021―Aug―18 Fluoxetine hydrochloride loaded lipid polymer hybrid nanoparticles showed possible efficiency against SARS-CoV-2 infection Shaymaa Elsayed Khate, Ahmed El-khouly, Hend Mohamed Abdel-Ba, Abdulaziz Mohsen Al-mahallawi, Dalia Mahmoud Ghorab
30 [GO] 2021―Jun―23 Continuous Manufacture of Hydroxychloroquine Sulfate Drug Products via Hot Melt Extrusion Technology to Meet Increased Demand During a Global Pandemic: From Bench to Pilot Scale Victoire de Margerie, Christopher McConville, Suha M. Dadou, Shu Li, Pascal Boulet, Lionel Aranda, Andrew Walker, Valentyn Mohylyuk, David S. Jones, Brian Murray, Gavin P. Andrews
31 [GO] 2021―Mai―06 Nasal vaccination against SARS-CoV-2: synergistic or alternative to intramuscular vaccines? Mattia Tiboni, Luca Casettari, Lisbeth Illum
32 [GO] 2021―Apr―15 Insulin fast-dissolving film for intranasal delivery via olfactory region, a promising approach for the treatment of anosmia in COVID-19 patients: Design, in-vitro characterization and clinical evaluation Soad A. Mohamad, Ahmed M. Badawi, Heba F. Mansour
33 [GO] 2021―Apr―09 mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability Linde Schoenmaker, Dominik Witzigmann, Jayesh A. Kulkarni, Rein Verbeke, Gideon Kersten, Wim Jiskoot, Daan Crommelin
34 [GO] 2021―Feb―03 Self-injectable extended release formulation of Remdesivir (SelfExRem): A potential formulation alternative for COVID-19 treatment Manali Patki, Siddhant Palekar, Sandra Reznik, Ketan Patel
35 [GO] 2020―Nov―07 Optimization and Evaluation of Propolis liposomes as a promising therapeutic approach for COVID-19 Hesham refaat, Fatma M. Mady, Hatem A. Sarhan, Heba S. Rateb, Eman Alaaeldin
36 [GO] 2020―Jul―25 The Lord of the NanoRings: cyclodextrins and the battle against SARS-CoV-2 Pablo F. Garrido, Martín Calvelo, Alexandre Blanco-González, Uxía Veleiro, Fabián Suárez, Daniel Conde, Alfonso Cabezón, Ángel Piñeiro, Rebeca Garcia-Fandino
37 [GO] 2020―Mai―16 Hand sanitisers amid CoViD-19: A critical review of alcohol-based products on the market and formulation approaches to respond to increasing demand Alberto Berardi, Diego R. Perinelli, Hamid A. Merchant, Lorina Bisharat, Iman A. Basheti, Giulia Bonacucina, Marco Cespi, Giovanni F. Palmieri
 [1] 

37 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.005 sec